Back
AnaptysBio Vs. Agios Pharmaceuticals Industry Stock Comparison
Sell
21
ANAB
AnaptysBio
Last Price:
19.05
Seasonality Move:
24.05%
Sell
42
AGIO
Agios Pharmaceuticals
Last Price:
53.81
Seasonality Move:
3.07%
Sell
21
AnaptysBio (ANAB)
is a Sell
Is AnaptysBio a Buy, Sell or Hold?
- The current AnaptysBio [ANAB] share price is $20.17. The Score for ANAB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- ANAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $55.40. The Score for AGIO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANAB Stock Price Chart
What is AnaptysBio's stock price today?
-
The AnaptysBio share price today is $20.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANAB is experiencing selling pressure, which indicates risk of future bearish movement.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $55.40
The current trend is moderately bullish and AGIO is experiencing selling pressure, which indicates risk of future bearish movement.
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.43 | Sell |
| Relative Strength Index (14 RSI): | 28.38 | Sell |
| Chaikin Money Flow: | -257294 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.37 - 33.73) | Sell |
| Bollinger Bands (100): | (26.68 - 37.5) | Sell |
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.65 | Buy |
| Relative Strength Index (14 RSI): | 63.97 | Buy |
| Chaikin Money Flow: | -815715 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.12 - 54.02) | Buy |
| Bollinger Bands (100): | (41.94 - 49.48) | Buy |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.22 | Sell |
| 20-day SMA: | 26.05 | Sell |
| 50-day SMA: | 31.43 | Sell |
| 200-day SMA: | 27.81 | Sell |
| 8-day EMA: | 21.64 | Sell |
| 20-day EMA: | 24.87 | Sell |
| 50-day EMA: | 29.02 | Sell |
| 200-day EMA: | 28.19 | Sell |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.74 | Sell |
| 20-day SMA: | 49.51 | Buy |
| 50-day SMA: | 46.24 | Buy |
| 200-day SMA: | 39.24 | Buy |
| 8-day EMA: | 55.34 | Buy |
| 20-day EMA: | 51.09 | Buy |
| 50-day EMA: | 47.59 | Buy |
| 200-day EMA: | 40.41 | Buy |
AnaptysBio Earnings Growth & ANAB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.47 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.31 per share, and a decrease next year of $16.57 per share.
AnaptysBio Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agios Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||